Clinical Certificate

Anxiety Disorders (Online)

Date: Thursday 21st January 2021 – Friday 22nd January 2021
Venue: Online via Zoom
Organised by: David Nutt and John Potokar

Programme (Draft)

Thursday 21 January
10:30–10:45 Welcome and Introduction
Dr John Potokar (Bristol)
10:45–12:15 Update on pharmacological treatment of anxiety disorders and post-traumatic stress disorder
Professor David Baldwin (Southampton)
12:15–13:15 Break
13:15–14:15 Evidence-based treatments for OCD - An update
Professor Naomi Fineberg (Hertfordshire)
14:15–14:30 Break
14:30–16:00 Two Groups
Group A: Anxiety in the Medical Setting
Dr John Potokar and Dr Nicola Taylor (Bristol)
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law (Bristol) and Dr Jan Melichar (Bristol)
16:00–16:15 Break
16:15–17:45 Two Groups (repeated)
Group A: Anxiety in the Medical Setting
Dr John Potokar and Dr Nicola Taylor
Group B: Benzodiazepines in Anxiety Disorders
Dr Fergus Law and Dr Jan Melichar
17:45 End of Thursday Sessions
Friday 22 January
09:00–09:15 Welcome
09:15–10:45 The fast and the slow: exploring the duality of anxiolytic action
Professor David Nutt (London)
10:45–11:00 Break
11:00–12:30 Practical therapy of anxiety: case studies
Professor David Nutt and Dr David Christmas (Cambridge)
12:30–13:15 Break
13:15–14:30 Two Groups
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt and Dr David Christmas
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick (London) and Dr David O'Regan (London)
14:30–14:45 Break
14:45–16:00 Two Groups (repeated)
Group A: Exploring Brain Mechanisms in SSRI Action
Professor David Nutt and Dr David Christmas
Group B: Insomnia and other Sleep Disturbances
Dr Hugh Selsick and Dr David O'Regan
16:00 End of meeting

Last edited 5th August 2020

Learning Objectives

At the end of one and a half day course, delegates will:

  • Be aware of current theories and the causes and neurochemistry of anxiety.
  • Know the pharmacology of both GABA and 5-HT acting anxiolytic drugs.
  • Have an understanding of the current clinical assessment of the various anxiety disorders.
  • Be aware of the merits and demerits of the various different classes of anxiolytic agents.
  • Understand the ongoing methodologies for investigating brain mechanisms of anxiety.
  • Know the clinical and pharmacology background of underpinning rational use of hypnotics.
  • Have an insight into the way alcohol acts on the brain and how these effects can be minimised.

This module is eligble for 10 CPD hours which are subject to peer group review.

Feedback from 2020 Module

"This was so well organised - thank you! And the content is highly relevant and pitched at a good level. The catering was also excellent!"

"Very unusual to have such fantastic, consistent excellence. Thank you!"

"Excellent content and engagement throughout – an always with BAP events!"

Print DOIs